Skip to main
WALD

WALD Stock Forecast & Price Target

WALD Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Waldencast is facing some challenges in the short term due to missed revenue expectations, margin pressure and a lack of guidance for FY26. However, the company's recent sale of Obagi Japan trademarks and improvements to the balance sheet through debt repayment demonstrate a commitment to improving financials. In the long term, the entry of Obagi into the filler market and momentum in their eCommerce channels show potential for increased growth. Risks to the investment include volatility in commodity costs, access to capital, and geopolitical uncertainty in the beauty and wellness industry.

Bears say

Waldencast is facing a negative outlook due to its ongoing strategic review, reliance on third-party suppliers and distributors, potential dilution from future securities, and concentration of share ownership among SPAC sponsors. Additionally, slowdown in the beauty market, ongoing SEC investigation, and potential inflation and supply chain pressures could add further strain on the company's financials. These factors raise concerns about the long-term sustainability and growth potential of Waldencast, leading to a negative outlook.

WALD has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waldencast Acquisition Corp (WALD) Forecast

Analysts have given WALD a Buy based on their latest research and market trends.

According to 3 analysts, WALD has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waldencast Acquisition Corp (WALD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.